Why “gold‑standard tools” are not enough in autism and ADHD assessment
Over recent years, the private neurodevelopmental sector has expanded rapidly. Long NHS waiting times have understandably pushed many families towards independent assessment, and in response a huge number of new clinics and companies have appeared. Many of these services promote the ADI‑R and ADOS‑2 as evidence of a “gold‑standard” assessment. On the surface, it sounds reassuring. But the reality is far more complex.
The ADI‑R and ADOS‑2 are valuable tools, but they were never designed to stand alone. They require deep clinical experience, an understanding of developmental history, and the ability to recognise subtle patterns across different contexts. Completing the tools is straightforward; interpreting them well takes years of specialist work. Without that experience, the tools can be misused, misinterpreted or over‑relied upon.
When “multidisciplinary” is actually a shortcut
A trend we see more often now is large private companies organising assessments so that one clinician completes the ADI‑R and another completes the ADOS‑2. It is often marketed as a multidisciplinary approach, and families understandably assume this means higher quality. But in practice, this split‑role model is usually a shortcut designed to increase profit and throughput, not clinical depth.
When different clinicians complete different parts of the assessment, no one has a full overview of the case. No one sees the whole developmental picture. No one holds the formulation. Instead, each clinician sees only a slice of the person’s presentation, and the final diagnostic decision is made by stitching together two separate pieces of information. It may look thorough from the outside, but clinically it is risky. Without an experienced clinician integrating everything, the assessment becomes fragmented, and the likelihood of misdiagnosis increases.
A good neurodevelopmental assessment is not about ticking off tools. It is about understanding the person. That requires continuity, context and a clinician who can hold the whole story.
Remote assessments used as another cost‑cutting measure
Another pattern we see is the increasing use of remote assessments for key parts of the diagnostic process. Remote appointments can be helpful in some situations, but they are often used by large corporations as a way to cut costs and speed up throughput. For example, a company may conduct the ADI‑R remotely, outsource the ADOS‑2 to a different clinician in another part of the country, and then have a third person write the report. This can be presented as flexible, efficient or modern, but in reality it further fragments the assessment.
Remote working removes important contextual information: how someone moves, interacts, responds to the environment, and manages transitions. These subtleties matter. When remote assessments are used primarily to reduce overheads rather than to support clinical need, the quality of the formulation suffers. The result is often a diagnosis based on isolated pieces of information rather than a coherent, integrated understanding of the individual.
When ADI/ADOS training becomes a tick‑box exercise
A related issue is the way large corporations now insist that clinicians complete ADI‑R or ADOS‑2 training as part of their recruitment criteria. On paper, this sounds like a commitment to quality. But in reality, it often becomes a tick‑box exercise. The emphasis is placed on having the certificate, not on developing the depth of experience needed to use these tools safely.
Clinicians may be encouraged to complete short courses so they can be deployed quickly into assessment roles, even if they have limited background in neurodevelopmental work. The assumption seems to be that once someone has “done the training”, they are ready to assess. But these tools were never designed to be used in isolation, nor to be mastered through brief workshops. Without years of supervised practice, exposure to diverse presentations and a strong grounding in developmental psychology, the tools can be misinterpreted, leading to inaccurate conclusions and over‑diagnosis.
This is not a criticism of individual clinicians. It is a reflection of how corporate systems prioritise efficiency over expertise.
Cerebro’s commitment to quality
Cerebro was created as a response to these trends. We wanted to offer families something different: personalised, thoughtful, high‑quality assessment carried out by clinicians with genuine expertise. We use structured tools when they are helpful, but we never rely on them alone. We integrate developmental history, observation, collateral information and careful clinical analysis.
Our goal is not simply to diagnose. It is to understand. Families come to us because they want clarity, not shortcuts. They want assessments that stand up to scrutiny and genuinely support long‑term wellbeing.
Cerebro 